Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 43.48 as of Monday, July 27, 2026.
Forward PE Ratio (43.48) = Close Price ($381.15) / Consensus Forward EPS ($8.95)
FORWARD PE RATIO
43.48
SECTOR MEDIAN · HEALTHCARE
18.46
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+135.54%
vs the sector median at left
Humana Inc.
Market Cap
$45.76B
Forward PE Ratio
43.48
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Humana Inc. (HUM) | $45.76B | 43.48 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.87B | 37.15 |
| Edwards Lifesciences Corporation (EW)vs › | $47.81B | 27.52 |
| Agilent Technologies, Inc. (A)vs › | $38.94B | 22.88 |
| Cardinal Health, Inc. (CAH)vs › | $53.72B | 21.29 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $37.17B | 36.45 |
| IQVIA Holdings Inc. (IQV)vs › | $35.59B | 16.24 |
| Becton, Dickinson and Company (BDX)vs › | $57.58B | 12.40 |
| Medline Inc. (MDLN)vs › | $33.57B | 25.58 |
| Zoetis Inc. (ZTS)vs › | $32.24B | 10.95 |
Trailing P/E
41.6
reported TTM EPS
Forward P/E
43.5
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $8.95 implies -4.3% EPS decline vs the reported trailing $9.35.
At today's $381.15 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $8.95 | $8.15 – $11.13 | 15 | 42.6x |
| 2027-12-31 | $16.13 | $13.27 – $20.52 | 16 | 23.6x |
| 2028-12-31 | $26.79 | $19.78 – $31.80 | 7 | 14.2x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
